Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
62.49
Dollar change
0.00
Percentage change
0.00
%
Index- P/E- EPS (ttm)- Insider Own46.72% Shs Outstand55.32M Perf Week0.13%
Market Cap3.74B Forward P/E- EPS next Y-1.31 Insider Trans13.16% Shs Float37.73M Perf Month0.90%
Income- PEG- EPS next Q-0.68 Inst Own49.91% Short Float1.91% Perf Quarter170.75%
Sales- P/S- EPS this Y32.12% Inst Trans- Short Ratio0.98 Perf Half Y-
Book/sh9.62 P/B6.50 EPS next Y6.96% ROA- Short Interest0.72M Perf Year-
Cash/sh9.03 P/C6.92 EPS next 5Y- ROE- 52W Range17.95 - 62.51 Perf YTD0.51%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-0.03% Beta-
Dividend TTM- Quick Ratio31.85 Sales past 5Y0.00% Gross Margin- 52W Low248.13% ATR (14)0.30
Dividend Ex-Date- Current Ratio31.85 EPS Y/Y TTM- Oper. Margin- RSI (14)88.17 Volatility0.05% 0.14%
Employees- Debt/Eq0.02 Sales Y/Y TTM- Profit Margin- Recom1.67 Target Price48.75
Option/ShortYes / No LT Debt/Eq0.01 EPS Q/Q- Payout- Rel Volume0.00 Prev Close62.49
Sales Surprise- EPS Surprise-83.54% Sales Q/Q- EarningsNov 13 AMC Avg Volume736.58K Price62.49
SMA200.34% SMA5012.04% SMA20069.38% Trades Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Oct-11-23Initiated Evercore ISI Outperform
Oct-10-23Initiated Truist Buy $29
Oct-10-23Initiated JP Morgan Overweight $30
Oct-10-23Initiated Jefferies Buy $35
Oct-06-23Initiated William Blair Outperform
Feb-28-24 11:28PM
Feb-26-24 08:35AM
Feb-23-24 06:59AM
Feb-14-24 04:40PM
Feb-12-24 06:59AM
08:55AM Loading…
Feb-07-24 08:55AM
Feb-02-24 11:58AM
Jan-29-24 11:02PM
Jan-27-24 12:16PM
Jan-25-24 12:22PM
07:17AM
Jan-23-24 02:45PM
Jan-08-24 10:06AM
Dec-29-23 07:33AM
Dec-27-23 05:37AM
06:56PM Loading…
Dec-26-23 06:56PM
03:31PM
02:34PM
02:15PM
01:57PM
01:03PM
12:39PM
12:33PM
12:05PM
11:47AM
11:42AM
11:19AM
10:10AM
09:35AM
09:23AM
07:13AM Loading…
07:13AM
07:09AM
07:08AM
07:02AM
Nov-13-23 04:01PM
Nov-06-23 04:05PM
Nov-01-23 06:00AM
Oct-24-23 08:00AM
Oct-18-23 07:00AM
Sep-19-23 04:01PM
Sep-14-23 06:51PM
Rayzebio, Inc. provides radiopharmaceutical medicines for cancer. It develops a pipeline against validated oncology drug targets to deliver radioisotopes that emit alpha particles such as Actinium-225. The company was founded by Deborah Charych, Aaron Kantoff and Aron Royston in January 2020 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Moran SusanCHIEF MEDICAL OFFICERJan 22Option Exercise3.2430,875100,035322,647Feb 06 06:11 PM
VIKING GLOBAL INVESTORS LP10% OwnerSep 19Buy18.001,388,88925,000,0024,899,144Sep 21 04:59 PM
VIKING GLOBAL INVESTORS LP10% OwnerSep 19Buy18.001,388,88925,000,0024,899,144Sep 21 05:00 PM
Katabi MahaDirectorSep 19Buy18.00472,2228,499,9961,209,764Sep 21 05:10 PM